July 14, 2023
We are delighted to share the exciting news that our PiVOT team, led by our Clinical Trial Manager, Ms. Lizbeth Ann Salonga; Business Development Head, Mr. Joseph Cheng; Senior Clinical Research Associate, Ms. Catherine Pinto; and Content Marketing Lead, Cheng Bigay will be attending the BIO Asia-Taiwan Exhibition 2023. The event is scheduled from July 27-30, 2023, at Taipei Nangang Exhibition Center, Taipei, Taiwan.
BIO Asia–Taiwan is Asia’s largest biotech networking event, jointly organized by the global Biotechnology Innovation Organization (BIO) and the Taiwan Bio Industry Organization (Taiwan BIO). It is a highly anticipated event that brings together industry professionals, researchers, investors, and policymakers from across the globe to discuss the latest advancements and opportunities in the biotech sector.
Apart from biotech, the event will feature special exhibition zones, such as smart medical devices, precision medicine, cell therapy, and regenerative medicine. These zones highlight the intersection of biotechnology with other cutting-edge technologies and medical fields, showcasing the potential for groundbreaking advancements in healthcare.
The organizers of the BIO Asia-Taiwan Exhibition emphasize the strong connection between innovative advances in biomedicine and digital technologies. Biotechnology is seen as the next driving force for Asia in the future, with the potential to revolutionize healthcare, improve patient outcomes, and drive economic growth.
Attending this prestigious event allows our PiVOT team to stay at the forefront of industry trends, connect with key stakeholders, and explore potential collaborations and partnerships. We are excited to showcase our expertise in clinical trials on this global platform.
We invite industry professionals, researchers, investors, and policymakers to connect with our team during the BIO Asia-Taiwan Exhibition 2023.
Search for PiVOT in the BIO partnering portal and arrange a meeting with our team.
Go BackJuly 17, 2024
June 27, 2024
June 30, 2024